Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Special Issue

KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease

Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, Dae Won Jun, Seung Up Kim

Clin Mol Hepatol. 2024;30(suppl):s5-s105. Published online August 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0506

View: 467 Download: 79

Guideline

KASL clinical practice guidelines for management of autoimmune hepatitis 2022

Clin Mol Hepatol. 2023;29(3):542-592. Published online May 3, 2023

DOI: https://doi.org/10.3350/cmh.2023.0087

View: 4552 Download: 333 Web of Science: 3 Crossref: 5

Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association

Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim

Clin Mol Hepatol. 2023;29(3):521-541. Published online July 1, 2023

DOI: https://doi.org/10.3350/cmh.2023.0202

View: 3654 Download: 219 Web of Science: 9 Crossref: 9

Editorial

Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan

San-Chi Chen

Clin Mol Hepatol. 2023;29(2):352-354. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0101

View: 2998 Download: 66

The clinical management of hepatocellular carcinoma in China: Progress and challenges

Shan Shan, Jidong Jia

Clin Mol Hepatol. 2023;29(2):339-341. Published online March 16, 2023

DOI: https://doi.org/10.3350/cmh.2023.0077

View: 3476 Download: 104 Web of Science: 4 Crossref: 5

Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma

Do Young Kim

Clin Mol Hepatol. 2023;29(2):335-338. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0107

View: 3098 Download: 55

What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?

Min Kyung Park, Yoon Jun Kim

Clin Mol Hepatol. 2023;29(2):332-334. Published online March 16, 2023

DOI: https://doi.org/10.3350/cmh.2023.0080

View: 2815 Download: 55 Web of Science: 1 Crossref: 1

Review

Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison

Yuri Cho, Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2023;29(2):252-262. Published online March 10, 2023

DOI: https://doi.org/10.3350/cmh.2023.0099

View: 4897 Download: 261 Web of Science: 18 Crossref: 24

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective

Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao

Clin Mol Hepatol. 2023;29(2):206-216. Published online December 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0402

View: 7099 Download: 474 Web of Science: 37 Crossref: 32

Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective

Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi

Clin Mol Hepatol. 2023;29(2):197-205. Published online January 5, 2023

DOI: https://doi.org/10.3350/cmh.2022.0404

View: 4867 Download: 241 Web of Science: 13 Crossref: 14

Guideline

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Clin Mol Hepatol. 2022;28(4):583-705. Published online October 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0294

View: 14816 Download: 766 Web of Science: 119 Crossref: 133

Review

Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound

Junghoan Park, Jeong Min Lee, Tae-Hyung Kim, Jeong Hee Yoon

Clin Mol Hepatol. 2022;28(3):362-379. Published online December 27, 2021

DOI: https://doi.org/10.3350/cmh.2021.0361

View: 6495 Download: 239 Web of Science: 18 Crossref: 20

Guideline

KASL clinical practice guidelines for management of chronic hepatitis B

Clin Mol Hepatol. 2022;28(2):276-331. Published online April 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0084 Correction in: Clin Mol Hepatol 2022;28(4):940

View: 11614 Download: 616 Web of Science: 47 Crossref: 55

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho

Clin Mol Hepatol. 2021;27(3):363-401. Published online June 22, 2021

DOI: https://doi.org/10.3350/cmh.2021.0178

View: 19502 Download: 1,242 Web of Science: 157 Crossref: 172

Review

Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee

Clin Mol Hepatol. 2020;26(4):411-429. Published online August 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0049

View: 15384 Download: 1,456 Web of Science: 66 Crossref: 66

Guideline

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

Clin Mol Hepatol. 2020;26(2):83-127. Published online January 10, 2020

DOI: https://doi.org/10.3350/cmh.2019.0010n

View: 22163 Download: 1,362 Web of Science: 78 Crossref: 75

Review

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update

Tae-Hyung Kim, So Yeon Kim, An Tang, Jeong Min Lee

Clin Mol Hepatol. 2019;25(3):245-263. Published online February 14, 2019

DOI: https://doi.org/10.3350/cmh.2018.0090

View: 19591 Download: 1,050 Web of Science: 144 Crossref: 154

KASL clinical practice guidelines for management of chronic hepatitis B

Clin Mol Hepatol. 2019;25(2):93-159. Published online June 12, 2019

DOI: https://doi.org/10.3350/cmh.2019.1002

View: 25575 Download: 653 Web of Science: 167 Crossref: 151

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

Clin Mol Hepatol. 2018;24(3):230-277. Published online July 9, 2018

DOI: https://doi.org/10.3350/cmh.2018.1005

View: 30289 Download: 786 Web of Science: 42 Crossref: 45

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

Clin Mol Hepatol. 2018;24(3):169-229. Published online August 10, 2018

DOI: https://doi.org/10.3350/cmh.2018.1004

View: 15032 Download: 226 Web of Science: 20 Crossref: 27

Liver Imaging

Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm

Chansik An, Gulbahor Rakhmonova, Jin-Young Choi, Myeong-Jin Kim

Clin Mol Hepatol. 2016;22(2):296-307. Published online June 15, 2016

DOI: https://doi.org/10.3350/cmh.2016.0028

View: 13008 Download: 245 Web of Science: 47 Crossref: 42

Review

Prevention of Hepatitis B reactivation in the setting of immunosuppression

Venessa Pattullo

Clin Mol Hepatol. 2016;22(2):219-237. Published online June 13, 2016

DOI: https://doi.org/10.3350/cmh.2016.0024

View: 17344 Download: 662 Web of Science: 87 Crossref: 90

KASL clinical practice guidelines: management of hepatitis C

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2016;22(1):76-139. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.76

View: 26831 Download: 209 Web of Science: 64 Crossref: 54

KASL clinical practice guidelines: management of chronic hepatitis B

Clin Mol Hepatol. 2016;22(1):18-75. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.18

View: 25284 Download: 262 Web of Science: 155 Crossref: 136

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

Su Jong Yu

Clin Mol Hepatol. 2016;22(1):7-17. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.7

View: 20345 Download: 550 Web of Science: 223 Crossref: 207

KASL clinical practice guidelines: Management of Hepatitis C

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2014;20(2):89-136. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.89

View: 25675 Download: 90 Web of Science: 25 Crossref: 30

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2013;19(4):325-348. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.325

View: 14091 Download: 164 Crossref: 95

KASL Clinical Practice Guidelines: Management of Alcoholic Liver Disease

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2013;19(3):216-254. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.216

View: 22170 Download: 164 Crossref: 30

Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions

Jae Young Jang, Moon Young Kim, Soung Won Jeong, Tae Yeob Kim, Seung Up Kim, Sae Hwan Lee, Ki Tae Suk, Soo Young Park, Hyun Young Woo, Sang Gyune Kim, Jeong Heo, Soon Koo Baik, Hong Soo Kim, Won Young Tak

Clin Mol Hepatol. 2013;19(1):1-16. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.1

View: 17142 Download: 330 Crossref: 60

Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period

Do Seon Song, Si Hyun Bae

Clin Mol Hepatol. 2012;18(3):258-267. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.258

View: 12849 Download: 142 Crossref: 65

1 | 2 |

Viewed By 4976	MAFLD: How is it different from NAFLD?
Viewed By 4839	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4760	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4476	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4433	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 95	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search